# Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System

Study · id `cardio:ct-nct01355406` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01355406](<https://clinicaltrials.gov/study/NCT01355406>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01355406

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 257 participants.

## Technical summary

Registry record NCT01355406. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09-16 (actual); primary completion 2016-01-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 257 participants (enrolled count; ClinicalTrials.gov record NCT01355406, source copy `cardio:ctgov-nct01355406-2018-06-29`, retrieved 2026-10-31)
- Started: 2011-09-16 (actual) (ClinicalTrials.gov record NCT01355406, source copy `cardio:ctgov-nct01355406-2018-06-29`, retrieved 2026-10-31)
- Primary completion: 2016-01-15 (actual) (ClinicalTrials.gov record NCT01355406, source copy `cardio:ctgov-nct01355406-2018-06-29`, retrieved 2026-10-31)
- Completion: 2018-04-10 (actual) (ClinicalTrials.gov record NCT01355406, source copy `cardio:ctgov-nct01355406-2018-06-29`, retrieved 2026-10-31)
- Countries: United States; Belgium (ClinicalTrials.gov record NCT01355406, source copy `cardio:ctgov-nct01355406-2018-06-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01355406-2018-06-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
- Acronym: OPEN
- Condition: Peripheral Artery Disease
- Condition: Peripheral Vascular Disease
- Condition: Vascular Disease
- Condition: Cardiovascular Diseases
- Condition: PAD
- Intervention (Device): FlexStent® Femoropopliteal Self Expanding Stent System
- Lead sponsor: Cordis US Corp.
- Lead sponsor class: INDUSTRY
- Collaborator: Massachusetts General Hospital
- Collaborator class: OTHER
- Collaborator: Prairie Education and Research Cooperative
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Cordis US Corp. (`cardio:org-cordis-us-corp`)
- Registry lists this organization as a collaborator: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)

## Provenance

Content hash: 1f70552f6e9a1f4f21d7ed11505e2eca2b50336df74f360f717f6937bde11b14
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
